Phibro Animal Health Corporation (NASDAQ:PAHC) CFO Richard G. Johnson sold 29,807 shares of the company’s stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $35.66, for a total transaction of $1,062,917.62. Following the transaction, the chief financial officer now owns 4,240 shares in the company, valued at $151,198.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) traded up 1.39% during trading on Friday, hitting $36.45. 48,087 shares of the company traded hands. Phibro Animal Health Corporation has a one year low of $24.83 and a one year high of $40.25. The stock has a market cap of $1.44 billion, a price-to-earnings ratio of 22.64 and a beta of 1.36. The firm has a 50 day moving average price of $38.35 and a 200-day moving average price of $33.49.

Phibro Animal Health Corporation (NASDAQ:PAHC) last released its earnings results on Wednesday, August 30th. The company reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.04. The business had revenue of $194.84 million for the quarter, compared to the consensus estimate of $192.47 million. Phibro Animal Health Corporation had a net margin of 8.45% and a return on equity of 47.88%. The firm’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same period last year, the firm posted $0.32 earnings per share. Analysts predict that Phibro Animal Health Corporation will post $1.57 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 27th. Stockholders of record on Wednesday, September 6th will be given a $0.10 dividend. This represents a $0.40 annualized dividend and a dividend yield of 1.11%. The ex-dividend date of this dividend is Friday, September 1st. Phibro Animal Health Corporation’s dividend payout ratio (DPR) is currently 24.69%.

TRADEMARK VIOLATION NOTICE: This article was first published by American Banking News and is owned by of American Banking News. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.americanbankingnews.com/2017/09/08/insider-selling-phibro-animal-health-corporation-pahc-cfo-sells-29807-shares-of-stock.html.

Several research analysts have weighed in on PAHC shares. Piper Jaffray Companies set a $35.00 target price on shares of Phibro Animal Health Corporation and gave the stock a “buy” rating in a research report on Friday, July 21st. Bank of America Corporation reaffirmed an “underperform” rating and issued a $33.00 price target on shares of Phibro Animal Health Corporation in a report on Wednesday, August 23rd. BidaskClub downgraded shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a report on Wednesday, June 14th. Credit Suisse Group downgraded shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and upped their price target for the company from $29.00 to $36.00 in a report on Friday, June 2nd. Finally, Zacks Investment Research raised shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a report on Thursday, May 11th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $33.33.

Several institutional investors have recently added to or reduced their stakes in PAHC. Janus Henderson Group PLC acquired a new stake in shares of Phibro Animal Health Corporation during the second quarter worth approximately $6,353,000. AJO LP acquired a new stake in shares of Phibro Animal Health Corporation during the second quarter worth approximately $5,815,000. FMR LLC boosted its holdings in shares of Phibro Animal Health Corporation by 31.9% during the second quarter. FMR LLC now owns 584,463 shares of the company’s stock worth $21,654,000 after purchasing an additional 141,274 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Phibro Animal Health Corporation by 8.2% during the first quarter. Vanguard Group Inc. now owns 1,729,406 shares of the company’s stock worth $48,597,000 after purchasing an additional 130,935 shares during the period. Finally, Ameriprise Financial Inc. boosted its holdings in shares of Phibro Animal Health Corporation by 50.6% during the second quarter. Ameriprise Financial Inc. now owns 339,996 shares of the company’s stock worth $12,599,000 after purchasing an additional 114,230 shares during the period. 48.35% of the stock is currently owned by institutional investors and hedge funds.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.